"
coinciding with the widespread availability of COVID-19 vaccines."
the physicians would have been the first to get emergency Pfizer in December..2020
and the first to get the Pfizer xs death effect....maybe 20-30/mnth for 3 months?
how to fake statistics!
Australia / NSW - reporting scheme has obviously been changed, so no transparancy between vax. and unvax. group is possible.
Hope of Intravenous Spike Protein Detoxification
Alkaline Serine Protease derived from River Worm Neanthes Japonica (Izuka)
By Peter A. McCullough, MD, MPH
As COVID-19 vaccine victims are waking up to the reality that their bodies have been genetically loaded with either Pfizer or Moderna modifications (~70% homologous) of the Wuhan Spike protein, a collective panic is driving a search for detoxification of this deadly protein proven to cause heart damage, neurological injury, blood clotting, and potentially more problems over the longer term. Recently, vulnerabilities have been discovered in Spike including proteolytic cleavage sites where the protein can be broken down by enzymes that could be suitable for drug development. In nature, there are many sources of such enzymes including worms.
EVA Project Finds 78% of Women Report Menstrual Changes after COVID-19 Vaccination
Premenstrual and Menstrual Symptoms Portend Infertility and Dysfunctional Uterine Bleeding
By Peter A. McCullough, MD, MPH
One of the consequences of young healthy woman receiving an unnecessary COVID-19 vaccine is the dangerous transition from being previously well to a new state of discomfort and or altered reproductive physiology. This is exactly what has happened to the vast majority of women in the childbearing age range with mRNA and adenoviral vaccination. Both forms of the vaccine use lipid nanoparticles which for years have been known to be taken up by reproductive glands (ovaries and testis) and dump their payload of genetic code for the WIV BA4/BA5 Spike protein which starts producing the tissue damaging Spike within an hour. The mRNA is now known to circulate in the bloodstream for 28 days and continue to bombard the ovaries with more mRNA throughout the ovulatory cycle. Genetic vaccines loaded on lipid nanoparticles, are almost by design as depicted by Wang et al destined to influence ovulatory cycles, gametocyte production and viability, thus interfering with the complex and delicate reproductive cycle of human beings.
Hope of Intravenous Spike Protein Detoxification
The Cure For Genetically Damaged/Transcribed Cells about study The Biphasic DoseResponse Treatment of Myocarditis and Pericarditis
The complete protocol includes biological extracts of the pericardium or myocardium, as medically identified, support for our inflammation fighters, and lastly a combination of biological extracts of DNA, RNA, mRNA tRNA, thymidine etc., which are used to shut off any artificial or corrupted gene expression. Patients were reporting back almost miraculous recoveries within 2 to 3 weeks of treatment which were confirmed by their treating cardiologists, by way of echocardiogram or MRI.
he complete protocol includes biological extracts of the pericardium or myocardium,
the author writes
"when the cases of myocarditis and pericarditis started rolling in.,,"
How many of these cases of cardiac inflammation
were due to the Pfizer Vaccine and not the Wuhan virus?
this alternative truth to the Pfizer-Biontech fairytale
of a state-of-the- art harmless 'vaccine'
has been on FB since 2021..
This alternative truth seems to be immune from attack by the FB immunity system so far..
+++++++++++++++++++++++by Gregorio+++++++++++++++++++++++++
"So many appear to be oblivious of the two central problems of these products:
1. What they are, and 2. What they do.
1. What they are
They are not any sort of advanced vaccine technology.
They are a deliberate and hasty off-label use of
30-40 year old molecular biology cell transfection reagents.
Here are the principal methods used in labs around the world to introduce exogenous gene constructs into stable cell lines...
A. Introduce the gene directly into a cell using a special needle.
B. Introduce the foreign gene into the cell using magnetic fields.
C. Introduce the foreign gene into the cell using ultrasound.
D. Introduce the foreign gene into the cells using electroporation to make the membrane temporarily leaky,
E. Introduce the foreign gene into the cells by precipitation of the gene in its viral vector by chemical means to make nanoparticles which stick the plasma membrane and are then internalized.
I used the phosphate precipitation method in both my doctoral and post-doctoral research. Pfizer uses this approach but with mRNA, skipping (basketing)the gene in a viral vector cassette.
F. Introduce the foreign gene into the cells using lipid micelles containing or other lipid particles incorporating the foreign gene in its viral vector. These products stick to the lipid bilayer of the cell’s plasma membrane, merge with it, and deliver their contents to the cytosol of the cell.
I used these products (such as Lipofectin) when generating stable transfectants. Moderna and Johnson&Johnson use variations on these methods.
G. Introduce the foreign gene into the cell by the use of a bio-engineered adenovirus that uses its coat proteins to manipulate cell surface receptors to endocytose the adenovirus. The virus does what it normally does, falls apart, and exposes the viral genome, or the gene construct of interest.
AstraZeneca uses this method. The company believed its approach would be safer and lead to fewer adverse outcomes because entry would be restricted only to those cells with a specific cell surface receptors, unlike the others (E and F) that are indiscriminate and will enter any cell they bump into.
2. What they do.
Their mechanism of action is not that of a vaccine. They contain nothing at all against which an adaptive immune response can be raised.
They are also made to be as invisible as possible to the innate immune system which otherwise would try toprevent them from entering healthy cells and infecting them with C19 viral RNA.
This primary mechanism of action of ALL viral RNA products consisting of hijacking a healthy cell to produce viral protein from a viral gene is simply the primary mechanism of action of viral infection.
In contrast, a proper viral protein vaccine introduces bits and pieces of viral proteins. These are visible and are detected as such by the innate immune system, cleaned up, and presented to the B and T cells of the adaptive immune system.
If recognized from a previous encounter, specific antibody and killer T cell production is ramped up.
If never before seen, then as many different specific antibodies and initiated T cells are produced as there are different epitopes on the viral debris cleaned up by the innate immune system.
Since no cells were compromised with viral RNA (because viral protein vaccines are viral proteins and have no means of entering healthy cells) the innate immune response is quickly extinguished but, without infection, one is left with adaptive immune protection IF one’s adaptive immune system is not impaired.
If it is impaired, though one derives little or no adaptive immune benefit, one also suffers no harm to healthy cells or from further immune inflammatory response.due to a proper vaccine
Such is not the case with viruses and viral RNA products
In either case, the introduction of viral genomic material and the hijacked production of viral protein from it have the following effects:
A. The compromised cells have cytoplasmic sensors that detect the presence of both viral mRNA and viral protein and signal that to the outside.
This is the minimum necessary condition for the cell to alert the innate immune system that it has been compromised by a virus and is in viral replication mode. The inevitable result is attack and destruction of host cells by innate immune inflammatory attacks. This is a disease process.
Since the innate immune system operates using a defense in depth strategy and since normal viruses can be detected at earliest points of entry, the innate immune system acts to sequester and take out the viruses at the earliest possible point and fewest possible numbers to prevent the viruses from gaining entry to more cells over a wider area.
The innate immune system’s levels of response range from local and limited to multi systemic and extreme and all depend on a number of different factors:
i. Detection of viral protein in the extracellular fluid compartment, either as attached to a virus or alone (as found in viral protein vaccines).
It triggers the innate immune system to sequester, clean up, and dispose of the viral debris.
ii. Detection of viral protein and viral mRNA inside compromised cells, whether by a virus or virus-like product.
This is a signal of a higher danger because it means more viruses in the pipeline. It triggers the innate immune system to attack and kill virus or viral RNA product-compromised cells.
The intensity of the attack depends on the number and distribution of the compromised cells. The more cells compromised and the more widespread in the body they are, the greater and more intense the innate immune inflammatory chemical attack on these cells.
Other healthy cells in the tissue can be damaged, leading to disability or death.
iii. As more organ systems are compromised, the innate immune attack is further ramped up.
iv. As cells are disrupted by the overproduction of viral proteins, viral proteins flood the extracellular fluid compartment, triggering the innate immune system to expand efforts to clean up.
And since contact with a single viral protein by an innate immune system player is indistinguishable from an encounter with a virus and since signaling by compromised cells has already indicated the presence of viral replication, encountering viral proteins in the extracellular fluid compartment only increases the urgency to control the infection.
v. If viral proteins are found adhering to the membranes of otherwise uncompromised cells, those cells are destroyed by both the innate immune system as well as by any killer T cells initiated to recognize the viral epitope.
vi. If the viral proteins are not cleared from the extracellular fluid compartment, which is drained by the lymphatic system, when the contents of the lymphatic system are dumped into the circulatory system through a portal near the heart, their detection by the innate immune system in the circulatory system triggers the innate immune system of the existence of viremia, meaning the entire body is now at risk of viral infection.
In a normal viral infection, this is the next to last stage leading to multi system viral infection.
But with the viral RNA products, there is multi system compromise without innate immune detection from the very beginning because the products are designed to be undetectable.
As a result, their earliest point of detection is after they have compromised healthy cells throughout the body, giving the appearance of a sudden, widespread, multi systemic infection, and THEN the viremic condition is detected.
It make no difference whatsoever that only one C19 viral gene and one C19 viral protein are in play. Their detection will signal everything that a full viral infection will signal. And because of this, they will trigger exactly the same immunological consequences.
As a result, the viral RNA of a C19 virus (that would be detected in the respiratory system as soon as it gained access to the ACE2-expressing cells and is sequestered in the pulmonary system by innate immune response from the earliest stages) is introduced in the worst possible way across the broadest possible number of cell targets simultaneously and generating some of the most powerful innate immune responses by the deliberately-engineered and unavoidable action of the primary mechanism of action of these viral RNA products.
And unlike viral protein vaccines which, if your adaptive immune system is impaired, will cause you no harm, the viral RNA products WILL compromise your healthy cells and WILL provoke innate immune inflammatory attacks to kill those compromised cells.
The effect?
If you are immune compromised and suffering multiple comorbid conditions, the viral RNA products will have AT least the same immunological consequences as any viral infection, but worse because they appear suddenly in widespread distribution and signaling multiple danger levels.
So, because of folks wanting to save a buck on real vaccine development (not that it was ever needed) by the dangerous off-label use of an invaluable research protocol to deliberately infect the recipients’ healthy cells as cheap, liability-free bioreactors, more people (over 5.61 billion) have been infected with C19 viral RNA more times (between 1 and 4) and in much more serious ways and in a shorter time than would ever have been affected by the actual virus.
And ALL of this stuff was known from the earliest moments both by those companies
and by almost everyone in the biological sciences who have used those cell transfection techniques and have the slightest amount of knowledge
of immune function and the viral primary mechanism of action.
Especially critics like Robert Malone and Peter McCullough, who appear to be talking about everything BUT the primary mechanism of action and appear to be reluctant to identify it as something they have worked with (as I have) for decades, but in a safe fashion.
German Mainstream Media: “Serious Flaws In Pfizer BioNTech Vaccine Study”…”Many Irregularities”
the fairytale...
Military Coercion and BigPharma greed
A.marriage of human failure
not just in Argentina..
USA Australia..?
https://vladtepesblog.com/wp-content/uploads//2023/01/TrevDoD-PR.pdf
FOR IMMEDIATE RELEASE January 5, 2022
New Docs Reveal Department of Defense Controlled COVID-19 Program from the Start
FDA Vaccine Approval Process was Theater
Asthma Drug Ciclesonide Causes Mutations of SARS-CoV-2
A new study published in the journal PNAS Nexus describes that the drug Ciclesonide, responsible for the suppression of replication of SARS-CoV-2, also causes mutations and makes them resistant to drugs. These mutants have adverse effects on humans and are likely to continue because they transmit from person to person. TrialSite has also reported a study that shows that an antiviral drug called Molnupiravir is also responsible for causing mutations in SARS-CoV-2.
The drug ciclesonide is used for the treatment of asthma and allergic rhinitis. It has safe anti-inflammatory properties. It has been reported that it also causes the suppression of the replication of SARS-CoV-2 as it is considered the blocker of replication. This drug went through different clinical trials to use against SARS-CoV-2 but failed to show satisfactory results.
When virus-infected cells were treated with 40μM ciclesonide in the laboratory, ciclesonide-resistant mutants were formed. It was observed that there were mutations in the non-structural proteins nsp3 and nsp4 of SARS-CoV-2. This shows that ciclesonide interferes with the transcription-replication machinery of the virus and results in the inhibition of the virus’ RNA replication. These mutants are likely to present in asthmatic patients infected with coronavirus because they use this medicine. These mutations occur frequently because SARS-CoV-2 spread globally.
The GISAID EpiCoV database uses Next-generation sequencing for genome sequencing. With the help of this database, it is possible to draw a phylogenetic tree for the recognition of new variants because the sequences of patients are registered in this database. This database helps to confirm that ciclesonide-resistant mutations occurred in the patients infected with the virus.
Results
Firstly, the potential of drug-resistant mutants was measured after a single mutation. A total of 8 independent clones are formed. Two of them infect the Calu3 cells and VeroE6 cells of the respiratory tract with their parental virus. Their amount was quantified by real-time PCR. The mutants’ growth pattern is the same as their parental virus but the ciclesonide-resistant mutants grow 30 times faster than their parents in the presence of 50μM ciclesonide.
The GISAID EpiCoV database was searched to identify the nucleotide substitutions nsp3 and nsp12. Spike mutations were identified in Omicron mutants and nsp3 mutations were observed in ciclesonide-resistant mutants. The data gathered from the time period between January 2020 to March 2022 was used to draw the phylogenetic tree with the help of the Next strain interface.
For the comparison of data, nsp12 mutation which is due to the antiviral drug remdesivir was used. The number of transitions was observed at higher levels than natural mutations and the number of transversions was also higher than random mutations. The same goes for the remdesivir resistant mutation and random mutations.
The occurrence of ciclesonide-resistant mutants is more common and they transfer from one person to another more rapidly. The maximum number of cases of resistant mutants was observed between June 2020 to November 2021 due to their high transmission rate which results in forming a large cluster of cases. But remdesivir-resistant mutants form small clusters and spread up to 112 cases in the database. Spike mutation and nsp3 mutation are observed in only one and three patients respectively. Ciclesonide and remdesivir-resistant mutants have the capability to start their replication process under high drug selection pressure.
Discussion
The asthma drug ciclesonide has been approved for use in treating the condition. It is used extensively and it has a large market in South America, North America, and the Asia-Pacific because it has very few side effects. Asthma and COVID-19 have similar symptoms like wheezing, shortness of breath, cough, etc.
Patients with asthma infected with COVID-19 are treated with this medicine to cure both diseases because ciclesonide stops the replication of SARS-CoV-2. When a high dose of this medicine is taken or taken without a doctor’s prescription by non-hospitalized asthma patients, it increases the chances of mutant formation. The formation of resistant mutants is due to high selection pressure on asthmatic patients infected with COVID-19.
Author
The lead author of the article is Akihiro Doi who is affiliated with the Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Funding and Conflict of Interest
The study was supported by the Japan Agency for Medical Research and Development (AMED) grant, the Japan Society for the Promotion of Science (JSPS) grant, and the Uehara Memorial Foundation grant.
The authors declare no conflict of interest
The complete protocol includes biological extracts of the pericardium or myocardium, as medically identified, support for our inflammation fighters, and lastly a combination of biological extracts of DNA, RNA, mRNA tRNA, thymidine etc., which are used to shut off any artificial or corrupted gene
Extract of whom???? Lab replicated ? Tissue therapy is a very old field. First they use new born lambs organs....
The Cure For Genetically Damaged/Transcribed Cells
What about this ? https://news.admin.net-abuse.e…crosoft-sues-200-spammers
Seems to be a scam!
The FDA's Gross Malfeasance With Ivermectin
Agency claims its smearing of wonder drug was a "recommendation"
Many readers of this Substack remember the FDA-Media Blitzkrieg waged against Ivermectin—the FDA-approved anti-parasitic medication hailed as a Wonder Drug for virtually eradicating River Blindness, thereby winning William C. Campbell, Satoshi Ōmura, and Youyou Tu the Nobel Prize in Medicine in 2015.
As Dr. McCullough and I document in our book, The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex, the “flooding the zone” campaign waged against ivermectin will go down in history as one of the most mendacious and perfidious in medical history. Ivermectin has one of the safest profiles in all of medicine and multiple studies prior to 2020 showed it to have potent anti-viral properties. Most importantly, Drs. Juliana and Jean-Jacques Rajter conducted a proper controlled trial of the drug in the hospital setting in 2020 and published their study in the prestigious CHEST journal of pulmonology. The FDA KNEW about Ivermectin’s excellent safety profile, and it KNEW about the evidence showing the drug’s strong signal of benefit. Nevertheless, the agency chose to suppress this evidence and conduct a smear campaign against the drug.
Dr. Makary debunks 5 popular COVID myths: Fauci, CDC 'were wrong on so many things'
Makary says the data has 'caught up to the lies' and misinformation
Dr. Makary debunks 5 popular COVID myths: Fauci, CDC 'were wrong on so many things' | Fox News
After The Wall Street Journal's bombshell report from Sunday detailed the Energy Department's admission that COVID-19 "most likely" leaked from a Wuhan, China lab, many are wondering – what else have the experts gotten wrong?
Fox News medical contributor Dr. Marty Makary joined Brian Kilmeade Thursday on "Fox & Friends" to debunk five of the most common myths, telling viewers that top health officials "gave us bad guidance from the start."
First on his list was the myth that natural immunity offered little protection compared to vaccines.
"160 studies have shown that natural immunity is as good or more effective, and the ultimate review was just published, so now it is a settled science."
The John Hopkins University professor and surgeon said public health officials assumed most Americans were "too stupid" to understand they did not need the COVID vaccine if they had natural immunity from contracting the virus.
US investment prior to Covid in mRNA 'vaccine'
https://www.bmj.com/content/bmj/380/bmj-2022-073747.full.pdf
"
In the 35 years before the covid-19 pandemic,
the US government directly invested more than $330m ..that made the development, testing, and rapid production of mRNA covid-19 vaccines possible.
US investment prior to Covid in mRNA 'vaccine'
Citation:: One of the greatest public health successes to come out
of the covid-19 pandemic was the development of safe
and effective mRNA vaccines against SARS-CoV-2
After how many lies do you stop reading a paper?? At least 4 can be found in the introduction. RNA technolgy is no vaccine its simple ever will be immune therapy. It is not even close to be safe. I still is a deadly cure and allowed only in terminal cancer therapy after requst to the ethic commitee...
Public health success = loss of 3 year of live expectance in USA... And the cure is not even against SARS-CoV-2, just fitted to one narrowly defined strain of SARS-CoV-2.
Dr. Makary debunks 5 popular COVID myths
"The weaponisation of medical research"
..
After the US GovHealth was sliced and diced by surgeon Makary
the FDA receive targeted therapy from oncologist Prasad
for their denial of the NEJM's caution to not poison youth with the booster ..
Prasad's rebuttal is PDQ one day after the FDA letter..
FDA.."the booster has an excellent safety profile just like the flu vaccine"
"
The last sentence is particularly problematic. Of course,
myocarditis in boys aged 16-24, will be seen with bivalent boosters,
and has been seen with monovalent boosting,
and is not like influenza vaccines at all. Get out of here.
Robert Califf likes to say, “misinformation is the leading cause of death”. The irony of that statement is that he invented it, and has no data to support it.
The same is true for bivalent boosters in people aged 18-49. Many European nations are not doing it. As seroprevalence rises, the harm/ benefit balance will shift towards harm. And at present, and when they gave EUA, they had no good evidence benefits outweigh harms.
This letter is emblematic of the FDA’s caliber of analysis—
very poor quality analyses used to push conclusions for policy decision it has already reached.
Marion Gruber and Phil Krause were correct to resign."
Chilean Researchers Pursue Microbiome & COVID-19 Angle—Potential Treatments Identified (Probiotics & their Metabolites)
Infection with SARS-CoV-2, a single-stranded RNA virus belonging to the Coronaviridae subfamily Orthocoronaviridae leading to COVID-19 occurs as the spike (S) proteins, supporting the binding of the pathogen to the ACE2 receptor present on epithelial cells. Researchers from Chile point out that the pathogen is likely to infect tissues highly expressing the ACE2 receptor, the lungs, and intestine. This likely leads to an impaired immune response or intestinal dysbiosis. To date, treatments centers around antivirals as well as antibiotics to control secondary infection, while national regulatory authorities have authorized vaccines targeting the pathogen. But vaccine uptake in low- and moderate-income countries (LMICs) suggests an ongoing possibly, growing risk factor. New alternatives, such as the use of immunobiotics, have been raised as potentially promising. This regimen, if ever shown to be effective, helps by stimulating intestinal immunity and pulmonary immunity via the intestine-lung axis.
This recent study, published in MDPI and led by Apolinaria Garcia-Cancino and colleagues at the University of Concepción in Chile, consisted of a literature review, and an in-silico analysis was performed to probe for the presence of genes related to the metabolites with possible anti-COVID-19 functions with the genomes of both probiotic strains--Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A.
The team annotated a draft of the genomes of both strains with a tool called Prokka, generating files that support posterior analysis of the genomes. Thereafter, the group employed use of the eggNOG-mapper tool to produce a metagenomic catalog of likely genes associated with enzymes or metabolites with possible effects against SARS-Cov-2.
By analyzing primarily, the symptomatology associated with infection, the Chilean scientists suggest probiotics as well as their metabolites might contribute to helping COVID-19 patients. The team analyzed two immunomodulating strains: 1) fermentum UCO-979C and 2) L. rhamnosus UCO-25A at the Laboratory of Bacterial Pathogenicity, University of Concepción (Chile). These may possibly offer benefits when confronting infection by SAR-CoV-2.
What’s next?
Next for the researchers is the search for commercial products and patents to treat COVID-19 opens the possibility of scaling the culturing of strains, improving the technology to generate a commercial product with a large health and social impact for the community.
EU Commissioner’s Deal with Pfizer Shrouded in Mystery and Possible Scandal. Not the First Time for Ursula Von der Leyen
TrialSite News has reported on the controversy of European Union (EU) Commissioner Ursula Von der Leyen and her relationship with the Pfizer Corporation. She apparently negotiated some of the COVID-19 vaccine deal via private text! European Members of Parliament (MEPs) are now demanding the immediate ouster of Von der Leyen due to several charges of conflicts of interest, ethics violations, and breaches of public trust. “The MEPs allege that Mrs. von der Leyen is part of unprecedented industry-government collusion leading to what they describe as a ‘gigantic COVID-19 scientific fraud and propaganda campaign that causes and continues to cause massive violation of human rights and freedom and is a threat to the democracy in Europe.’ The MEPs raise several allegations of conflicts of interest and ethics violations, thus raising the urgent demand for her resignation.” It appears the accusations against Ms. Von der Leyen won’t be going away any time soon and will only increase.
Emails and Text Messages
As TrialSite’s Sonia Elijah reported in October of 2022, “Ursula von der Leyen has been under intense public scrutiny over her private negotiations of a multi-billion-euro vaccine deal (the EU’s biggest contract) via secret texts and phone calls made with Pfizer’s CEO, Albert Bourla, contravening the Commission decision for a steering board to ‘provide guidance throughout the evaluation process.’ Furthermore, she refused to grant public access to the secretive text messages exchanged between Bourla and herself, when called to do so.”
Now, the European Ombudsman, Emily O’Reilly says the secrecy over the text message exchanges between Van der Leyen and Albert Bourla are “fueling suspicion”. “We need to hear what went on, otherwise it’s going to drag on. So, it just won't go away," O’Reilly said.
A report in the New York Times in October of 2021, claimed Von der Leyen and Bourla were exchanging texts and phone calls for a month before a deal was struck between the EU and Pfizer without revealing the financials of the deal. Bourla said he and Ms. Von der Leyen had “developed a deep trust, because we got into deep discussions. She knew details about the variants, she knew details about everything. So that made the discussion way more engaged.” The contract permitted the vaccine to be manufactured in Europe by BioNTech and allowed for a “different” range of vaccine products. Reportedly, the EU agreed to pay more for the Pfizer jab than the United States. The EU paid over $23 per shot on a total of up to 1.8 billion doses.
Deal Shrouded in Mystery
The Ombudsman and the EU would like to know more about the text exchanges between Von der Leyen and Bourla, but according to the Commission, the texts are “no longer available”. Von der Leyen claims the texts were "short-lived, ephemeral documents". Ombudsman O’Reilly claims the secrecy of the deal is only “fueling suspicion”. “It’s the gift that keeps on giving to people who are hostile to the EU and who are anti-vax, because it can feed into the narrative that something is being hidden,” says O’Reilly. It also didn’t help that Albert Bourla refused to appear at a special hearing by the European Parliament and then the politicians threatened to ban Pfizer employees and lobbyists from entering the European governmental institution. The New York Times is now suing the EU for access to the texts between Von der Leyen and Bourla.
Von der Leyen No Stranger to Scandal
When Von der Leyen was the German defense minister, she was accused of awarding “lucrative” contracts to outside consultants without proper oversight. There was also a question of whether a network of “personal connections” helped the deals. What Von der Leyen’s defense ministry spent on consultants and what was reported were vastly different. And her ministry wasn’t helpful when investigated by a committee. Von der Leyen’s tenure as EU Commissioner seems oddly familiar to her time as the German defense minister. Apparently, she has found a willing partner in the power of Pfizer and Albert Bourla.
